FINISHED DOSAGE FORMULATIONS
Drug : LORAZEPAM
Dosage Form : TABLET; ORAL
Application Number : 72928
Country : US
Patented : No

Drug : LORAZEPAM
Dosage Form : TABLET; ORAL
Application Number : 72927
Country : US
Patented : No

Drug : LORAZEPAM
Dosage Form : TABLET; ORAL
Application Number : 72926
Country : US
Patented : No

Drug : METHYLPREDNISOLONE
Dosage Form : TABLET; ORAL
Application Number : 40232
Country : US
Patented : No

HYDROCHLOROTHIAZIDE; TRIAMTERENE
Drug : TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Dosage Form : TABLET; ORAL
Application Number : 71851
Country : US
Patented : No

Drug : LORAZEPAM
Dosage Form : TABLET; ORAL
Application Number : 203572
Country : US
Patented : No

Drug : LAMOTRIGINE
Dosage Form : TABLET; ORAL
Application Number : 90401
Country : US
Patented : No

Drug : ERYTHROCIN STEARATE
Dosage Form : TABLET; ORAL
Application Number : 60359
Country : US
Patented : No

Drug : ATIVAN
Dosage Form : TABLET; ORAL
Application Number : 17794
Country : US
Patented : No

DROSPIRENONE; ETHINYL ESTRADIOL
Drug : DROSPIRENONE AND ETHINYL ESTRADIOL
Dosage Form : TABLET; ORAL-28
Application Number : 204848
Country : US
Patented : No

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 23
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 45.28
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 20
Potency Unit : MG/5ML

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 45.8
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 4
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 21
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 5
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 40
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 40
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLACRILIN POTASSIUM
Route : ORAL
CAS : 65405-55-2
UNII : 0BZ5A00FQU
Potency Amount : 10
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
Application : Disintegrants & Superdisintegrants
Excipient Details : It is used in tablet disintegration and taste masking of bitter drugs.
Application : Disintegrants & Superdisintegrants
Excipient Details : It is used as a disintegrating agent.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Polacrilin Potassium
Dosage Form : Capsule, Granule / Pellet, Orodispersible Tablet, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants
Application : Disintegrants & Superdisintegrants
Excipient Details : PolyIon 909 is used as a disintegrant and dissolution enhancer in oral solids such as tablets, capsules, pellets, and orally disintegrating tablets.
Pharmacopoeia Ref : USPNF
Technical Specs : Contains 0.5 to 10% of tablet weight
Ingredient(s) : Polacrilin Potassium
Dosage Form : Capsule, Granule / Pellet, Orodispersible Tablet, Tablet
Grade : Not Available
Category : Granulation
Application : Granulation
Excipient Details : Wet Granulation and Direct Compression
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Polacrilin Potassium
Dosage Form : Granule / Pellet, Orodispersible Tablet, Tablet
Grade : Not Available
Category : Direct Compression
Application : Direct Compression
Excipient Details : Wet Granulation and Direct Compression
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Polacrilin Potassium
Application : Solubilizers
Excipient Details : PolyIon 909 is used as a disintegrant and dissolution enhancer in oral solids such as tablets, capsules, pellets, and orally disintegrating tablets.
Pharmacopoeia Ref : USPNF
Technical Specs : Contains 0.5 to 10% of tablet weight
Ingredient(s) : Polacrilin Potassium
MARKET PLACE
REF. STANDARDS & IMPURITIES